Clinical Trial Update: Trial to Evaluate UltraSound in the Treatment of Tibial Fractures [NA]

View source ↗

Summary

A trial evaluating ultrasound therapy for tibial fractures conducted by Bioventus LLC was terminated; results were posted on 2015-12-08.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tibial Fracture

Drugs mentioned

• EXOGEN Bone Growth Stimulator (low-intensity pulsed ultrasound)

Snippet

Sponsor: Bioventus LLC | Conditions: Tibial Fractures | NA | Status: TERMINATED | Results posted: 2015-12-08